by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Jun 13, 2019 | Drug Importation
This week, Florida’s Republican Governor Ron DeSantis signed into a law HB 19 to create a state prescription drug importation program. The goal is to lower the state’s prescription drug bill and the prices Florida residents pay at pharmacy counters by importing lower-cost medicines from Canada and other countries that have similarly strict pharmaceutical regulatory standards.
The main point of this blog post is to state that this law in Florida, much like the laws that have passed in Vermont and Colorado, create WHOLESALE not PERSONAL drug importation programs.
(more…)Tagged with: Governor Ron DeSantis
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Jun 6, 2019 | Drug Prices
I’ve recently been exercising bragging rights about our new and improved drug price comparisons. Americans seeking medicine from Canada and other countries are finding better deals on generics right here at home. But the crisis of high drug prices in the U.S. persists when it comes to brand medications. Recent price research by the Journal of the American Medical Association shows that brand name drug prices have increased by 76% over just the past six years.
This week, PharmacyChecker released new price analysis
showing potential
savings for 10 popular patented drugs, comparing U.S. discounted medication
prices with those available at accredited international online pharmacies. The
average discount from Canadian pharmacies is 75%. If ordering from farther abroad,
it’s 90%.
(more…)Tagged with: Journal of the American Medical Association
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | May 31, 2019 | Drug Safety
“Dispense as Written” are the words found on prescriptions in the U.S. when the prescriber wants the patient to take the brand drug, not the generic. Many who read Katherine Eban’s new book – Bottle of Lies: The Inside Story of the Generic Drug Boom – will conclude that they would like to see “DAW” on their prescriptions.
Bottle of Lies teaches its readers that generic drugs are not as good as the FDA claims. It shows that poor manufacturing practices, mostly in India and China, but also in the U.S., are the leading cause of substandard drugs being sold in U.S. pharmacies and throughout the world. More ominously, India and China intentionally ship even lower quality and, in some cases, worthless drugs to poor countries in Africa and Southeast Asia where regulations are weak or non-existent.
(more…)Tagged with: Bottle of Lies, generics, Katherine Eban
